Company · CIK 1709401

# Rubius Therapeutics, Inc.

| CIK | [1709401](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001709401) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-08-31 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-265482 | Shelf Withdrawn | 2022-06-08 | 2023-02-22 | 3 |
| 333-232955 | Shelf Effective | 2019-08-01 | 2021-03-18 | 4 |
| 333-225840 | IPO Final prospectus | 2018-06-22 | 2018-07-18 | 5 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-02-22 | [RW](https://www.sec.gov/Archives/edgar/data/1709401/000110465923024021/0001104659-23-024021-index.htm) Withdrawn | 333-265482 | 0001104659-23-024021 |
| 2022-06-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1709401/999999999522001831/9999999995-22-001831-index.htm) Declared effective | 333-265482 | 9999999995-22-001831 |
| 2022-06-08 | [S-3](https://www.sec.gov/Archives/edgar/data/1709401/000110465922069304/0001104659-22-069304-index.htm) Shelf registered | 333-265482 | 0001104659-22-069304 |
| 2021-03-18 | [424B5](https://www.sec.gov/Archives/edgar/data/1709401/000110465921038061/0001104659-21-038061-index.htm) Shelf takedown | 333-232955 | 0001104659-21-038061 |
| 2021-03-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1709401/000110465921036395/0001104659-21-036395-index.htm) Shelf takedown | 333-232955 | 0001104659-21-036395 |
| 2019-08-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1709401/999999999519001940/9999999995-19-001940-index.htm) Declared effective | 333-232955 | 9999999995-19-001940 |
| 2019-08-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1709401/000104746919004493/0001047469-19-004493-index.htm) Shelf registered | 333-232955 | 0001047469-19-004493 |
| 2018-07-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1709401/000104746918005073/0001047469-18-005073-index.htm) Final prospectus | 333-225840 | 0001047469-18-005073 |
| 2018-07-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1709401/999999999518001813/9999999995-18-001813-index.htm) Declared effective | 333-225840 | 9999999995-18-001813 |
| 2018-07-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1709401/000104746918004887/0001047469-18-004887-index.htm) Amendment | 333-225840 | 0001047469-18-004887 |
| 2018-07-02 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1709401/000104746918004849/0001047469-18-004849-index.htm) Amendment | 333-225840 | 0001047469-18-004849 |
| 2018-06-22 | [S-1](https://www.sec.gov/Archives/edgar/data/1709401/000104746918004710/0001047469-18-004710-index.htm) Registration filed | 333-225840 | 0001047469-18-004710 |
| 2018-04-13 | [DRS](https://www.sec.gov/Archives/edgar/data/1709401/000091205718000178/0000912057-18-000178-index.htm) Draft made public | 377-02021 | 0000912057-18-000178 |

[All filings of this company](https://equitycapital.markets/filings?cik=1709401) · [CSV](https://equitycapital.markets/filings.csv?cik=1709401)

---
Source page: https://equitycapital.markets/company/1709401 · Data: U.S. SEC EDGAR · CC BY 4.0